Screener
Keros Therapeutics KROS Q4 2025 Annual earnings
Reported March 4, 2026 · Before market open
Revenue$385.0KMiss by $3.3M
EPS-$0.86Miss by $0.37
Revenue estimate$3.7M
EPS estimate-$0.49
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$14.8M
EPS estimate-$0.96
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Keros Therapeutics report Q4 2025 earnings?
- Keros Therapeutics (KROS) reported Q4 2025 earnings on March 4, 2026 before market open.
- What were Keros Therapeutics's Q4 2025 revenue and EPS?
- Keros Therapeutics reported revenue of $385.0K and eps of $-0.86 for Q4 2025.
- Did Keros Therapeutics beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $3.7M by $3.3M. EPS missed the consensus estimate of $-0.49 by $0.37.
- How did Keros Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 87.3% from $3.0M a year earlier and eps grew 24.6% from $-1.14.
- Where can I find Keros Therapeutics's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001664710-26-000017) and the 10-K periodic report (0001664710-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.
